| Sanofi finally seals the deal to buy Genzyme. |
|
| Wall Street Journal: Sanofi-Aventis acquired Genzyme for $74 a share, or a total of $20.1 billion plus a contingent value right, in a giant step toward reshaping the company for future business. |